Medios AG (MEDOF)
Medios AG operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Berlin, DE. The stock last traded at $50.00, up 0.00% on the session, giving a market capitalisation of $1.28B. On trailing twelve-month figures it carries a trailing P/E of 20.73, a net margin of 0.7%. Its beta of 1.29 implies it has historically moved more than the broad market.
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Medios AG is most often compared with the following Healthcare names: